The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Immune response to reovirus (REO) in phase I study with chemotherapy in patients with KRAS mutant metastatic colorectal cancer (mCRC).

Ruwan  Parakrama

Employment - Regeneron

Stock and Other Ownership Interests  - Regeneron

Imran  Chaudhary

No Relationships to Disclose

Matthew C.  Coffey

Employment - Oncolytics

Research Funding - Oncolytics

Sanjay  Goel

Research Funding - Oncolytics (Inst)

Patents, Royalties, Other Intellectual Property - I have a patent with a co-inventor, John Mariadason, Ph.D, entitled "Method Of Determining The Sensitivity Of Cancer Cells To EGFR Inhibitors Including Cetuximab, Panitumumab And Erlotinib.", Patent No. 20090258364

Radhashree  Maitra

No Relationships to Disclose